Chlorpheniramine (CPAM) is a chiral antihistaminic drug commercialized as a
racemic mixture. The intestinal absorption and metabolism of CPAM have bee
n investigated in rat using in vivo (oral and IV administration), in situ (
intestinal loop model), and in vitro (everted sac model) experiments. Oral
and IV administrations of 20 mg/kg of the racemic mixture show that the pha
rmacokinetics of CPAM are stereoselective, with higher AUCs for the (+)-S-e
nantiomer compared to its antipode. The monodesmethyl metabolite (DCPM) was
quantifiable in blood and its pharmacokinetics are stereoselective after o
ral but not after IV administration. Experiments using intestinal loops and
everted sacs showed that the absorption is not stereoselective and that in
vivo stereoselective formation of DCPM is presumably due to stereoselectiv
e hepatic metabolism. Moreover, the in vitro and in situ absorption of CPAM
are not modified by modulators of P-glycoprotein and cytochromes P450 (cyc
losporin A, ketoconazole). Chirality 13:207-213, 2001. (C) 2001 Wiley-Liss,
Inc.